Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,197.00    -18.00 (-1.48%)
Bid:
1,198.00
Ask:
1,200.00
Spread: 2.00 (0.167%)
Market Cap: £832.43m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

16 Nov 2010 07:00

RNS Number : 2224W
CVS Group plc
16 November 2010
 



Tuesday 16th November 2010

CVS Group plc ("CVS" or the "Company")

Acquisition

CVS Group plc

 

 

Acquisition of St David's Veterinary Hospital

 

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of St David's Veterinary Hospital (SDVH). SDVH is the centre of the small animal part of the St David's Veterinary group, one of the longest established and largest veterinary groups in the UK. It split into different speciality groups many years ago and the Small Animal Hospital is renowned throughout the South West as a leading centre for orthopaedic surgery. Peter Attenburrow will remain in charge of the business and will concentrate on his orthopaedic skills, with CVS providing full managerial support. This should result in improved capacity and services to the many referring practices that send cases to St David's for treatment.

The acquisition brings the total number of surgeries acquired to date in 2010 to 45 including a laboratory and a referral centre.

In total the group now operates 214 surgeries, 6 diagnostic labs, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

The acquisition of SDVH is deemed to be a substantial transaction under the AIM Rules.

In the year ended 31 July 2009, SDVH achieved profit before tax of approximately £430,000 on turnover of approximately £1,858,000. The Company is acquiring the trade and assets of both St David's Veterinary Group and St David's Veterinary Clinic Limited and includes fixed assets of approximately £122,000 as at 31 July 2009. The consideration for the acquisition is £1,900,000 which includes £300,000 of deferred consideration but excludes payment in respect of stock and is being met entirely from existing cash resources. The practice employs 7 professional vets and 28 staff in total.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "SDVH is a long established business and we are delighted to be continuing to add to our portfolio following our acquisitions earlier in the year. We look forward to working with the team at St David's to help continue the high level of animal care and customer service that they have been delivering to date."

For further enquiries please contact:

 

CVS Group plc

 

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Brewin Dolphin

 

Matt Davis

0845 213 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFEDLTLELII
Date   Source Headline
9th Jan 20184:55 pmRNSHolding(s) in Company
5th Jan 20184:15 pmRNSHolding(s) in Company
4th Jan 20182:35 pmRNSHolding(s) in Company
2nd Jan 20188:35 amRNSTotal Voting Rights
2nd Jan 20187:00 amRNSDirectorate Change
29th Dec 201710:05 amRNSHolding(s) in Company
22nd Dec 20178:32 amRNSHolding(s) in Company
19th Dec 20177:00 amRNSBlock Admission
19th Dec 20177:00 amRNSExercise of Options, Directors' Dealing & TVR
18th Dec 20174:00 pmRNSHolding(s) in Company
13th Dec 20173:07 pmRNSExercise of Options & TVR
8th Dec 20174:39 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirector/PDMR Shareholding
7th Dec 20175:14 pmRNSHolding(s) in Company
30th Nov 20174:44 pmRNSTotal Voting Rights
30th Nov 20171:39 pmRNSResult of AGM
30th Nov 20177:00 amRNSAGM Statement
14th Nov 201712:12 pmRNSHolding(s) in Company
9th Nov 20174:15 pmRNSExercise of Options & TVR
2nd Nov 201710:33 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20174:14 pmRNSTotal Voting Rights
24th Oct 20172:41 pmRNSBlock listing Interim Review
24th Oct 20171:39 pmRNSExercise of Options & TVR
9th Oct 20174:57 pmRNSHolding(s) in Company
6th Oct 20174:23 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPreliminary Results
20th Sep 20175:24 pmRNSHolding(s) in Company
12th Sep 20173:41 pmRNSHolding(s) in Company
4th Sep 20172:53 pmRNSHolding(s) in Company
16th Aug 20173:46 pmRNSHolding(s) in Company
14th Aug 20173:10 pmRNSExercise of Options & TVR
31st Jul 201712:08 pmRNSExercise of Options & TVR
31st Jul 20177:00 amRNSTrading Update
26th Jul 20172:32 pmRNSHolding(s) in Company
25th Jul 20172:22 pmRNSExercise of Options & TVR
13th Jul 20173:39 pmRNSExercise of Options & TVR
7th Jul 20175:38 pmRNSHolding(s) in Company
4th Jul 20179:05 amRNSHolding(s) in Company
3rd Jul 20173:17 pmRNSExercise of Options & TVR
30th Jun 20173:59 pmRNSHolding(s) in Company
30th Jun 20172:57 pmRNSExercise of Options & TVR
2nd Jun 201711:38 amRNSHolding(s) in Company
26th May 20171:43 pmRNSHolding(s) in Company
25th May 20175:33 pmRNSExercise of Options & Total Voting Rights
24th May 20172:12 pmRNSHolding(s) in Company
16th May 20171:52 pmRNSHolding(s) in Company
3rd May 20173:44 pmRNSHolding(s) in Company
2nd May 20172:04 pmRNSExercise of Options and Total Voting Rights
26th Apr 20173:32 pmRNSHolding(s) in Company
3rd Apr 20172:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.